Funding
BIOTEC is supporting the CMCB Technology Platform by an application-oriented research project (Molekulares Bioengineering von Proteinen, Zellen und Geweben - No. 100344812) and a project to support the improvement of the research infrastructure (Moderne Forschungsinfrastruktur für molekulares Bioengineering von Proteinen, Zellen und Geweben - No. 100347528), which are both funded by the European Union EFRE initiative and the Free State of Saxony. Within this framework the CMCB TP CFs Mass Spectrometry, Electron Microscopy and Histology, Light Microscopy, as well as Microstructure are funded. All four CFs and their subprojects are extremely data-intensive and are made possible by a corresponding high-performance IT landscape, which are also funded within these projects.
Brief description of the projects: The complexity of living cells poses extraordinary challenges for research. Biology means understanding complexity on different scales - from the molecular level via structures and processes of medium size to the physiological interactions of cells during interaction in organisms. For a complete understanding of these complex phenomena in cells and organisms, cross-scale analysis of biological systems is necessary. The combination of microscopic and macroscopic knowledge can only be achieved through the research activities of dedicated scientists who can rely on the expertise and support of internationally recognized experts in the respective technological field.
Therefore, our goal is the development of an optimally complementary and cross-scale spectrum of technologies from single molecule analysis methods with ultra-high resoluation, subcellular and cellular imaging, to the contruction of macrscopic instruments and tisuue generation in labratories and the clinic this repertoire will be integrated in so called core facilities (CFs) in the CMCB technology Platform (CMCB TP) of the CMCB/BIOTEC, which provides state-of-the-art scientific equipment and technologies for innovative research and technology development. Thus, the developed technologies are available for use by a wide range of applications not only at the CMCB/BIOTEC, but are also easily accessible by other university insitutes and the DRESDEN concept partners. This enables internationally competitive basic research and with this unique combination of bioanalytical skills the worldwide recognized strenghts of the research location Dresden will be further consolidated.
